Common Stock, Shares Authorized of CRISPR Therapeutics AG from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
CRISPR Therapeutics AG quarterly Common Stock, Shares Authorized history and change rate from Q4 2015 to Q3 2025.
  • CRISPR Therapeutics AG Common Stock, Shares Authorized for the quarter ending 30 Sep 2025 was 132M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

CRISPR Therapeutics AG Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 132M 0 0% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 132M 0 0% 30 Jun 2025 10-Q 04 Aug 2025
Q1 2025 132M +2.02M +1.55% 31 Mar 2025 10-Q 06 May 2025
Q4 2024 132M +5.94M +4.7% 31 Dec 2024 10-Q 10 Nov 2025
Q3 2024 132M 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 132M 30 Jun 2024 10-Q 05 Aug 2024
Q1 2024 130M -19.9M -13.2% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 127M -23.8M -15.8% 31 Dec 2023 10-K 11 Feb 2025
Q1 2023 150M +4.98M +3.43% 31 Mar 2023 10-Q 08 May 2023
Q4 2022 150M +4.98M +3.43% 31 Dec 2022 10-K 21 Feb 2024
Q3 2022 150M +4.98M +3.43% 30 Sep 2022 10-Q 01 Nov 2022
Q2 2022 150M +4.98M +3.43% 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 145M +30.2M +26.2% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 145M +30.2M +26.2% 31 Dec 2021 10-K 21 Feb 2023
Q3 2021 145M +30.2M +26.2% 30 Sep 2021 10-Q 03 Nov 2021
Q2 2021 145M +30.2M +26.2% 30 Jun 2021 10-Q 29 Jul 2021
Q1 2021 115M +11.3M +10.8% 31 Mar 2021 10-Q 27 Apr 2021
Q4 2020 115M +11.3M +10.8% 31 Dec 2020 10-K 15 Feb 2022
Q3 2020 115M +59.5M +107% 30 Sep 2020 10-Q 28 Oct 2020
Q2 2020 115M +59.7M +108% 30 Jun 2020 10-Q 27 Jul 2020
Q1 2020 104M +50.6M +94.8% 31 Mar 2020 10-Q 28 Apr 2020
Q4 2019 104M +13.6M +15% 31 Dec 2019 10-K 16 Feb 2021
Q3 2019 55.7M +3.78M +7.29% 30 Sep 2019 10-Q 28 Oct 2019
Q2 2019 55.4M +7.92M +16.7% 30 Jun 2019 10-Q 29 Jul 2019
Q1 2019 53.3M +6.16M +13.1% 31 Mar 2019 10-Q 29 Apr 2019
Q4 2018 90.3M +49.3M +120% 31 Dec 2018 10-K 12 Feb 2020
Q3 2018 51.9M +11M +26.9% 30 Sep 2018 10-Q 07 Nov 2018
Q2 2018 47.5M +6.96M +17.2% 30 Jun 2018 10-Q 07 Aug 2018
Q1 2018 47.2M +6.91M +17.2% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 41.1M +839K +2.09% 31 Dec 2017 10-K 25 Feb 2019
Q3 2017 40.9M +35.2M +622% 30 Sep 2017 10-Q 08 Nov 2017
Q2 2017 40.6M 30 Jun 2017 10-Q 10 Aug 2017
Q1 2017 40.3M 31 Mar 2017 10-Q 11 May 2017
Q4 2016 40.3M +34.7M +628% 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 5.66M 30 Sep 2016 10-Q 22 Nov 2016
Q4 2015 5.53M 31 Dec 2015 10-K 10 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.